Global Pharma copyAccording to Reuters, “China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population…original “Made in China” treatments won’t arrive overnight, but multinationals are already encountering more competition from local generic drugs that look set for a quantum leap in quality.”  Read more at http://www.reuters.com/article/2015/11/30/us-china-pharmaceuticals-idUSKBN0TI00J20151130#tXDgEwdrxSWf1b0a.97